ClearPoint Neuro director granted 12,820 RSUs

LIAU LINDA M. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

LIAU LINDA M. reported acquisition or exercise transactions in this Form 4 filing.

ClearPoint Neuro, Inc. director Linda M. Liau reported an equity award of restricted stock units. She received 12,820 restricted stock units, each representing a contingent right to receive one share of ClearPoint Neuro common stock. The units were granted at a price of $0.00 per unit.

The restricted stock units vest on the earlier of the first anniversary of the grant date or the day immediately preceding the company’s 2027 annual meeting of stockholders. Following this grant, she directly holds 12,820 restricted stock units corresponding to 12,820 shares of common stock.

Insider Trade Summary

Grant/Award: 12,820 shares

Grant/Award 1 txn

Insider LIAU LINDA M.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	12,820	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 12,820 contracts (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.
2. F2. The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders.

Key Figures

RSUs granted: 12,820 restricted stock units Grant price per unit: $0.00 per unit Underlying common shares: 12,820 shares +2 more

5 metrics

RSUs granted 12,820 restricted stock units Grant to director Linda M. Liau on 2026-05-21

Grant price per unit $0.00 per unit Restricted stock unit award

Underlying common shares 12,820 shares Common stock underlying the RSUs

Holdings after transaction 12,820 restricted stock units Total derivative holdings following the grant

Derivative transactions reported 1 transaction Single derivative-type grant on this Form 4

Key Terms

Restricted Stock Units, contingent right, vest, annual meeting of stockholders

4 terms

Restricted Stock Units financial

"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."

vest financial

"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

annual meeting of stockholders financial

"The restricted stock units vest on the earlier of the first anniversary of the grant date, or the day immediately preceding the Company's 2027 annual meeting of stockholders."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ClearPoint Neuro (CLPT) director Linda M. Liau report on this Form 4?

She reported receiving 12,820 restricted stock units. Each unit represents a contingent right to one share of ClearPoint Neuro common stock, reflecting an equity-based award rather than an open-market purchase or sale of existing shares.

How many ClearPoint Neuro (CLPT) restricted stock units were granted to Linda M. Liau?

Linda M. Liau was granted 12,820 restricted stock units. These units correspond to 12,820 underlying shares of ClearPoint Neuro common stock and represent a single derivative-type grant reported in this Form 4 filing.

What are the vesting terms of Linda M. Liau’s ClearPoint Neuro (CLPT) restricted stock units?

The restricted stock units vest on the earlier of the first anniversary of the grant date or the day immediately preceding ClearPoint Neuro’s 2027 annual meeting of stockholders, tying vesting to either a time-based milestone or the company’s future shareholder meeting.

Does this ClearPoint Neuro (CLPT) Form 4 show any open-market stock purchases or sales?

No open-market purchases or sales are reported. The filing shows a single acquisition coded as a grant or award of 12,820 restricted stock units, rather than a transaction in freely tradable common shares on the market.

How many ClearPoint Neuro (CLPT) restricted stock units does Linda M. Liau hold after this transaction?

After the reported grant, she directly holds 12,820 restricted stock units. These units each represent a contingent right to receive one share of ClearPoint Neuro common stock, subject to the specified vesting conditions described in the Form 4 footnotes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/26/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LIAU LINDA M.

(Last) (First) (Middle)

C/O CLEARPOINT NEURO, INC.

120 S. SIERRA AVE., SUITE 100

(Street)

SOLANA BEACH CALIFORNIA 92075

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ClearPoint Neuro, Inc. [ CLPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	05/21/2026		A		12,820		(2)	(2)	Common Stock	12,820	$0	12,820	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.

2. The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders.

	/s/ Danilo D'Alessandro, by Power of Attorney for Linda M. Liau	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)